共 50 条
- [2] Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine NEUROLOGY INTERNATIONAL, 2023, 15 (01): : 273 - 284
- [4] Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials The Journal of Headache and Pain, 2021, 22
- [5] Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
- [8] Comparison study between erenumab, fremanezumab, and galcanezumab in the preventive treatment of high frequency episodic migraine and chronic migraine Neurological Sciences, 2022, 43 : 5757 - 5758
- [10] Shift from chronic to episodic migraine frequency in a long-term phase 3 study of galcanezumab JOURNAL OF HEADACHE AND PAIN, 2025, 26 (01):